裕同科技(002831.SZ):吳蘭蘭累計減持1754.2萬股 減持計劃已實施完成
格隆匯2月17日丨裕同科技(002831.SZ)公佈,近日,公司收到吳蘭蘭出具的《關於股份減持計劃實施進展暨實施完成的告知函》,獲悉吳蘭蘭於2020年2月17日通過大宗交易方式合計減持公司股份92.6479萬股(佔公司總股本0.1056%),其於2020年2月13日至2020年2月17日累計減持1754.1971萬股,此次減持計劃已實施完成。
此次減持後,吳蘭蘭持有股份4.56億股,佔總股本比例51.9486%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.